The potential role of interleukins and interferons in ovarian cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The potential role of interleukins and interferons in ovarian cancer
Authors
Keywords
-
Journal
CYTOKINE
Volume 171, Issue -, Pages 156379
Publisher
Elsevier BV
Online
2023-09-26
DOI
10.1016/j.cyto.2023.156379
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
- (2023) Liya Ding et al. Journal for ImmunoTherapy of Cancer
- Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses
- (2023) Nirmala Chandralega Kampan et al. Cancers
- Vorinostat decrease M2 macrophage polarization through ARID1A6488delG/HDAC6/IL-10 signaling pathway in endometriosis-associated ovarian carcinoma
- (2023) Tsung-Hua Hsieh et al. BIOMEDICINE & PHARMACOTHERAPY
- Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer
- (2023) M. Falcinelli et al. BRAIN BEHAVIOR AND IMMUNITY
- Butein Inhibits Cell Growth by Blocking the IL-6/IL-6Rα Interaction in Human Ovarian Cancer and by Regulation of the IL-6/STAT3/FoxO3a Pathway
- (2023) Sun-Ae Park et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Crosstalk of Inflammatory Cytokines within the Breast Tumor Microenvironment
- (2023) Ola Habanjar et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cross-talk between cancer stem cells and immune cells: potential therapeutic targets in the tumor immune microenvironment
- (2023) Bo Wu et al. Molecular Cancer
- ISG20 stimulates anti-tumor immunity via a double-stranded RNA-induced interferon response in ovarian cancer
- (2023) Zhigao Chen et al. Frontiers in Immunology
- Identification of novel candidate targets for suppressing ovarian cancer progression through IL-33/ST2 axis components using the system biology approach
- (2023) Geovanny Genaro Reivan Ortiz et al. Frontiers in Molecular Biosciences
- Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer
- (2023) Magdalena Bizoń et al. Journal of Personalized Medicine
- Immunomodulatory Role of Interferons in Viral and Bacterial Infections
- (2023) Paulina Mertowska et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interferon-ε is a tumour suppressor and restricts ovarian cancer
- (2023) Zoe R. C. Marks et al. NATURE
- Inhibition of GP130/STAT3 and EMT by combined bazedoxifene and paclitaxel treatment in ovarian cancer
- (2022) Sun-Ae Park et al. ONCOLOGY REPORTS
- Engineering interferons and interleukins for cancer immunotherapy
- (2022) Patrick G. Holder et al. ADVANCED DRUG DELIVERY REVIEWS
- The significance of interferon gamma inducible protein 16 (IFI16) expression in drug resistant ovarian cancer cell lines
- (2022) Justyna Borucka et al. BIOMEDICINE & PHARMACOTHERAPY
- Inability of ovarian cancers to upregulate their MHC-class I surface expression marks their aggressiveness and increased susceptibility to NK cell-mediated cytotoxicity
- (2022) Nishant Chovatiya et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Combined inhibition of IL‑6 and IL‑8 pathways suppresses ovarian cancer cell viability and migration and tumor growth
- (2022) Ruijie Zhang et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Lactobacillus reuteri Releasing IL-22 (LR-IL-22) Facilitates Intestinal Radioprotection for Whole-Abdomen Irradiation (WAI) of Ovarian Cancer
- (2022) Diala F. Hamade et al. RADIATION RESEARCH
- Tumor-derived Lysophosphatidic Acid Blunts Protective Type-I Interferon Responses in Ovarian Cancer
- (2022) Chang-Suk Chae et al. Cancer Discovery
- The Interleukin-1 (IL-1) Superfamily Cytokines and Their Single Nucleotide Polymorphisms (SNPs)
- (2022) Payam Behzadi et al. Journal of Immunology Research
- Mitochondrial transcription factor B2 overexpression increases M2 macrophage infiltration via cytosolic mitochondrial DNA-stimulated Interleukin-6 secretion in ovarian cancer
- (2022) Weilu Wu et al. Bioengineered
- IFNγ-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling
- (2022) Sveta Padmanabhan et al. CELLULAR SIGNALLING
- Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
- (2022) Daniel S. Green et al. CLINICAL CANCER RESEARCH
- Interleukin-17 Family Cytokines in Metabolic Disorders and Cancer
- (2022) Eileen Victoria Meehan et al. Genes
- Meta-analyses reveal serum or plasma Interleukin-6 as a biomarker for malignant ovarian neoplasia
- (2022) Andrei Pașca et al. CYTOKINE
- Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-β/STAT1 signaling
- (2022) Siyu Liu et al. EXPERIMENTAL CELL RESEARCH
- The role of interferons in ovarian cancer progression: Hinderer or promoter?
- (2022) Taiqing Liu et al. Frontiers in Immunology
- Layer‐by‐layer interleukin‐12 nanoparticles drive a safe and effective response in ovarian tumors
- (2022) Antonio E. Barberio et al. Bioengineering & Translational Medicine
- Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line
- (2022) Qun Liu et al. Biomedicines
- Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and targeted treatment of autoimmune and inflammatory diseases
- (2021) Giulio Cavalli et al. AUTOIMMUNITY REVIEWS
- Roles of Neutrophil Granule Proteins in Orchestrating Inflammation and Immunity
- (2021) Amira Othman et al. FEBS Journal
- Interleukin‑8 released by cancer‑associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells
- (2021) Suyanee Thongchot et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- IL-37bΔ1-45 suppresses the migration and invasion of endometrial cancer cells by targeting the Rac1/NF-κB/MMP2 signal pathway
- (2021) Xishuang Wang et al. LABORATORY INVESTIGATION
- Role of the IL‑33/ST2 receptor axis in ovarian cancer progression (Review)
- (2021) Ning Liu et al. Oncology Letters
- Downregulation of RIPK4 Expression Inhibits Epithelial-Mesenchymal Transition in Ovarian Cancer through IL-6
- (2021) Huan Yi et al. Journal of Immunology Research
- Kaempferia parviflora extract inhibits TNF-α-induced release of MCP-1 in ovarian cancer cells through the suppression of NF-κB signaling
- (2021) Phatarawat Thaklaewphan et al. BIOMEDICINE & PHARMACOTHERAPY
- IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway
- (2021) A. H. Gao et al. Clinical & Translational Oncology
- Cytokines: From Clinical Significance to Quantification
- (2021) Chao Liu et al. Advanced Science
- The Assessment of IL-21 and IL-22 at the mRNA Level in Tumor Tissue and Protein Concentration in Serum and Peritoneal Fluid in Patients with Ovarian Cancer
- (2021) Aleksandra Mielczarek-Palacz et al. Journal of Clinical Medicine
- Cancer-Associated Fibroblast-Derived Interleukin-8 Promotes Ovarian Cancer Cell Stemness and Malignancy Through the Notch3-Mediated Signaling
- (2021) Zhaodong Ji et al. Frontiers in Cell and Developmental Biology
- IFNγ induces JAK1/STAT1/p65 NFκB-dependent interleukin-8 expression in ovarian cancer cells, resulting in their increased migration
- (2021) Sveta Padmanabhan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Implication of IL-17 producing ɑβT and γδT cells in patients with ovarian cancer
- (2020) Xian Chen et al. HUMAN IMMUNOLOGY
- Th17 Cells and IL-17 As Novel Immune Targets in Ovarian Cancer Therapy
- (2020) Monika Bilska et al. Journal of Oncology
- IL-6 and IL-8 are involved in JMJD2A-regulated malignancy of ovarian cancer cells
- (2020) Haiyu Zhang et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas
- (2020) Paula Carolina Arvelos Crispim et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Deubiquitinase USP35 restrains STING-mediated interferon signaling in ovarian cancer
- (2020) Jiawen Zhang et al. CELL DEATH AND DIFFERENTIATION
- Interferons: role in cancer therapy
- (2020) Mohadeseh Haji Abdolvahab et al. Immunotherapy
- IL-10 and Its Related Superfamily Members IL-19 and IL-24 Provide Parallel/Redundant Immune-Modulation in Loa loa Infection
- (2020) Alessandra Ricciardi et al. JOURNAL OF INFECTIOUS DISEASES
- P-MAPA activates TLR2 and TLR4 signaling while its combination with IL-12 stimulates CD4+ and CD8+ effector T cells in ovarian cancer
- (2020) Henrique Spaulonci Silveira et al. LIFE SCIENCES
- Long non-coding RNA THOR promotes ovarian Cancer cells progression via IL-6/STAT3 pathway
- (2020) Jing Ge et al. Journal of Ovarian Research
- Long non-coding RNA SNHG12 promotes immune escape of ovarian cancer cells through their crosstalk with M2 macrophages
- (2020) Min Qian et al. Aging-US
- Investigation of the Impact from IL-2, IL-7, and IL-15 on the Growth and Signaling of Activated CD4+ T Cells
- (2020) Canaan Coppola et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- IL-6 promotes nuclear translocation of HIF-1α to aggravate chemoresistance of ovarian cancer cells
- (2020) Shiwen Xu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The role of vascular endothelial growth factor, interleukin 8, and insulinlike growth factor in sustaining autophagic DIRAS3-induced dormant ovarian cancer xenografts
- (2019) Weiqun Mao et al. CANCER
- Follicular regulatory T cells infiltrated the ovarian carcinoma and resulted in CD8 T cell dysfunction dependent on IL-10 pathway
- (2019) Li Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines
- (2019) Masaaki Murakami et al. IMMUNITY
- Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancer
- (2019) Daniel S Green et al. Immunotherapy
- The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer
- (2019) Eva Pastille et al. Mucosal Immunology
- Interleukin‐17 is associated with expression of programmed cell death 1 ligand 1 in ovarian carcinoma
- (2019) Aeri Aotsuka et al. CANCER SCIENCE
- Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
- (2019) Anquan Shang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Fluid shear stress-induced IL-8/CXCR signaling in human ovarian cancer cells
- (2019) Lei Sun et al. Translational Cancer Research
- Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
- (2019) I-Tsu Chyuan et al. Cells
- IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer
- (2019) Isac Souza Silva Rodrigues et al. IMMUNOLOGICAL INVESTIGATIONS
- IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment
- (2019) Chunyan Yu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IL‐8 promotes cell migration through regulating EMT by activating the Wnt/β‐catenin pathway in ovarian cancer
- (2019) Jirui Wen et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- P-MAPA and Interleukin-12 Reduce Cell Migration/Invasion and Attenuate the Toll-Like Receptor-Mediated Inflammatory Response in Ovarian Cancer SKOV-3 Cells: A Preliminary Study
- (2019) Luiz Antonio Lupi et al. MOLECULES
- P-MAPA and IL-12 Differentially Regulate Proteins Associated with Ovarian Cancer Progression: A Proteomic Study
- (2019) Luiz Antonio Lupi Júnior et al. ACS Omega
- Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling
- (2018) Yingxia Ning et al. BIOMEDICINE & PHARMACOTHERAPY
- The role of cytokines in T-cell memory in health and disease
- (2018) Miro E. Raeber et al. IMMUNOLOGICAL REVIEWS
- Negative regulation of type I IFN signaling
- (2018) Kei-Ichiro Arimoto et al. JOURNAL OF LEUKOCYTE BIOLOGY
- A Phase 1 trial of autologous monocytes stimulated ex vivo with Sylatron® (Peginterferon alfa-2b) and Actimmune® (Interferon gamma-1b) for intra-peritoneal administration in recurrent ovarian cancer
- (2018) Daniel S. Green et al. Journal of Translational Medicine
- Superagonist IL-15-armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 Blockade
- (2018) Stacy J. Kowalsky et al. MOLECULAR THERAPY
- Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance
- (2018) Wei Zhou et al. ONCOGENE
- Combined Immunotherapy (OK-432, IL-2) With Chemotherapy Decrease the Recurrence Rate in Advanced Ovarian Cancer
- (2018) Yi-Lun Wang et al. Reproductive Sciences
- IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer
- (2018) Hassan Yousefi et al. TUMORI
- GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade
- (2018) Mingo Ming-Ho Yung et al. Theranostics
- Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral Infection
- (2018) Torben Knuschke et al. Frontiers in Immunology
- IL-6/IL-6R pathway is a therapeutic target in chemoresistant ovarian cancer
- (2018) Hassan Yousefi et al. TUMORI JOURNAL
- Follicular helper T cells promote the effector functions of CD8+ T cells via the provision of IL-21, which is downregulated due to PD-1/PD-L1-mediated suppression in colorectal cancer
- (2018) Weiwei Shi et al. EXPERIMENTAL CELL RESEARCH
- Toll Like Receptor-7 and -9 agonists improve Hepatitis C Virus replication and infectivity inhibition by plasmacytoid dendritic cells
- (2018) B. Dominguez-Molina et al. JOURNAL OF VIROLOGY
- The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
- (2018) Nicolo Costantino Brembilla et al. Frontiers in Immunology
- Interleukin 30 to Interleukin 40
- (2018) Jovani Catalan-Dibene et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers
- (2018) Wouter Scheper et al. NATURE MEDICINE
- Leukemia inhibitory factor functions in parallel with interleukin-6 to promote ovarian cancer growth
- (2018) Karen McLean et al. ONCOGENE
- IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
- (2018) Landon Browning et al. Cancer Management and Research
- Improved therapeutic efficacy of mammalian expressed-recombinant interferon gamma against ovarian cancer cells
- (2017) Ali Razaghi et al. EXPERIMENTAL CELL RESEARCH
- IL-15 super-agonist (ALT-803) enhances natural killer (NK) cell function against ovarian cancer
- (2017) M. Felices et al. GYNECOLOGIC ONCOLOGY
- Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
- (2017) Marcela Moisés Maluf Sanguinete et al. IMMUNOLOGICAL INVESTIGATIONS
- Biology of IL-38 and its role in disease
- (2017) Frank L. van de Veerdonk et al. IMMUNOLOGICAL REVIEWS
- Overview of the IL-1 family in innate inflammation and acquired immunity
- (2017) Charles A. Dinarello IMMUNOLOGICAL REVIEWS
- IL-3R-alpha blockade inhibits tumor endothelial cell-derived extracellular vesicle (EV)-mediated vessel formation by targeting the β-catenin pathway
- (2017) Giusy Lombardo et al. ONCOGENE
- Assessment of Th17 lymphocytes and cytokine IL-17A in epithelial ovarian tumors
- (2017) Izabela Winkler et al. ONCOLOGY REPORTS
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- IL-36α suppresses proliferation of ovarian cancer cells
- (2017) Lei Chang et al. TUMOR BIOLOGY
- Interleukin-6 Family Cytokines
- (2017) Stefan Rose-John Cold Spring Harbor Perspectives in Biology
- Targeting IL-10 Family Cytokines for the Treatment of Human Diseases
- (2017) Xiaoting Wang et al. Cold Spring Harbor Perspectives in Biology
- Serum and peritoneal fluid concentrations of soluble human leukocyte antigen, tumor necrosis factor alpha and interleukin 10 in patients with selected ovarian pathologies
- (2017) Olimpia Sipak-Szmigiel et al. Journal of Ovarian Research
- IL-6R/STAT3/miR-204 feedback loop contributes to cisplatin resistance of epithelial ovarian cancer cells
- (2017) Xiaolan Zhu et al. Oncotarget
- Inflammatory responses and inflammation-associated diseases in organs
- (2017) Linlin Chen et al. Oncotarget
- Adipose Stromal Cells from Visceral and Subcutaneous Fat Facilitate Migration of Ovarian Cancer Cells via IL-6/JAK2/STAT3 Pathway
- (2017) Boyun Kim et al. Cancer Research and Treatment
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma
- (2017) Eva Brencicova et al. PLoS One
- Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients
- (2016) Junwei Huo et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Apoptotic properties of the type 1 interferon induced family of human mitochondrial membrane ISG12 proteins
- (2016) Heidi Gytz et al. BIOLOGY OF THE CELL
- The CXCL8-CXCR1/2 pathways in cancer
- (2016) Qian Liu et al. CYTOKINE & GROWTH FACTOR REVIEWS
- IL-27 suppresses SKOV3 cells proliferation by enhancing STAT3 and inhibiting the Akt signal pathway
- (2016) Zhu Zhang et al. MOLECULAR IMMUNOLOGY
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Effect of targeted silencing of IL-8 on in vitro migration and invasion of SKOV3 ovarian cancer cells
- (2016) Yanyu Li et al. Oncology Letters
- A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancer
- (2015) E. M. Dijkgraaf et al. ANNALS OF ONCOLOGY
- IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
- (2015) K Abiko et al. BRITISH JOURNAL OF CANCER
- Polymorphism of the IL-8 gene and the risk of ovarian cancer
- (2015) D. Koensgen et al. CYTOKINE
- IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients
- (2015) Yu-Li Chen et al. ENDOCRINE-RELATED CANCER
- Interferon alpha-inducible protein 27 promotes epithelial–mesenchymal transition and induces ovarian tumorigenicity and stemness
- (2015) Shuqin Li et al. JOURNAL OF SURGICAL RESEARCH
- Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo
- (2015) QI YOU et al. Molecular Medicine Reports
- Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways
- (2015) Xiaoguang Tong et al. Molecular Oncology
- A network map of Interleukin-10 signaling pathway
- (2015) Renu Verma et al. Journal of Cell Communication and Signaling
- IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumorsin vivo
- (2015) Mythili Koneru et al. OncoImmunology
- Therapeutic DC vaccination with IL-2 as a consolidation therapy for ovarian cancer patients: a phase I/II trial
- (2014) Soyoung Baek et al. Cellular & Molecular Immunology
- Interleukin-8 promotes human ovarian cancer cell migration by epithelial–mesenchymal transition induction in vitro
- (2014) J. Yin et al. Clinical & Translational Oncology
- Molecular Pathways: IL11 as a Tumor-Promoting Cytokine--Translational Implications for Cancers
- (2014) M. Ernst et al. CLINICAL CANCER RESEARCH
- Murine CD27(-) V 6(+) T cells producing IL-17A promote ovarian cancer growth via mobilization of protumor small peritoneal macrophages
- (2014) M. Rei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice
- (2014) Yunxia Zhang et al. Journal of Ovarian Research
- Revisiting the 1986 Molecular Cloning of Interleukin 6
- (2014) Toshio Hirano Frontiers in Immunology
- The role of intratumoral and systemic IL-6 in breast cancer
- (2013) Christine Dethlefsen et al. BREAST CANCER RESEARCH AND TREATMENT
- A novel melittin-MhIL-2 fusion protein inhibits the growth of human ovarian cancer SKOV3 cells in vitro and in vivo tumor growth
- (2013) Mingjun Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The IL-18 Antagonist IL-18-Binding Protein Is Produced in the Human Ovarian Cancer Microenvironment
- (2013) G. Carbotti et al. CLINICAL CANCER RESEARCH
- Proteasome Inhibition Increases Recruitment of IκB Kinase β (IKKβ), S536P-p65, and Transcription Factor EGR1 to Interleukin-8 (IL-8) Promoter, Resulting in Increased IL-8 Production in Ovarian Cancer Cells
- (2013) Bipradeb Singha et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery of a Novel Orally Active Small-Molecule gp130 Inhibitor for the Treatment of Ovarian Cancer
- (2013) S. Xu et al. MOLECULAR CANCER THERAPEUTICS
- Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer
- (2013) T Xiang et al. ONCOGENE
- The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13
- (2013) RANRAN WANG et al. ONCOLOGY REPORTS
- Recombinant Production of Human Interleukin 6 in Escherichia coli
- (2013) Henrik Nausch et al. PLoS One
- Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study
- (2013) F. Simpkins et al. Cancer Immunology Research
- Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer
- (2012) Chan-zhen Liu et al. Chinese Journal of Cancer Research
- Interleukin-8 secretion by ovarian cancer cells increases anchorage-independent growth, proliferation, angiogenic potential, adhesion and invasion
- (2012) Yue Wang et al. CYTOKINE
- Effect of plasmid-mediated stable interferon-γ expression on proliferation and cell death in the SKOV-3 human ovarian cancer cell line
- (2011) Huiming Lv et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma
- (2010) Yun-Sook Kim et al. BMC CANCER
- Augmenting Therapy of Ovarian Cancer Efficacy by Secreting IL-21 Human Umbilical Cord Blood Stem Cells in Nude Mice
- (2010) Weihua Hu et al. CELL TRANSPLANTATION
- Effects of Siltuximab on the IL-6-Induced Signaling Pathway in Ovarian Cancer
- (2010) Y. Guo et al. CLINICAL CANCER RESEARCH
- Endometrioid ovarian cancer and endometriotic cells exhibit the same alteration in the expression of interleukin-1 receptor II: To a link between endometriosis and endometrioid ovarian cancer
- (2010) Mamadou Keita et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
- Expression of interleukin-1 (IL-1) ligands system in the most common endometriosis-associated ovarian cancer subtypes
- (2010) Mamadou Keita et al. Journal of Ovarian Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now